Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective st…
Gabellier L; Peterlin P; Thepot S; Hicheri Y; Paul F; Gallego-Hernanz MP; Bertoli S; Turlure P; Pigneux A; Guieze R; Ochmann M; Malfuson JV; Cluzeau T; Thomas X; Tavernier E; Jourdan E; Bonnet S; Tudesq JJ; Raffoux E.
Ann Hematol
(Unknown)
Published: 2024
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a m…
Zhou H; Wang Y; Chen J; He A; Jin J; Lu Q; Zhao Y; Li J; Hou M; Su L; Lai X; Wang W; Liu L; Ma Y; Gao D; Lai W; Zhou X; Jing H; Zhang J; Yang W; Ran X; Lin C; Hao J; Xiao T; Huang Z; Zhu Z; Wang Q; Fang B; Wang B; Song Y; Cai Z; Liu B; Zhu Y; Yang X; Kang X; Li J; Chen W.
Ann Hematol
(Unknown)
Published: 2023
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to pr…
Demel I; Skopal D; Šafránková E; Rozsívalová P; Jindra P; Šrámek J; Turková A; Vydra J; Labská K; Vedrová J; Čerňan M; Szotkowski T; Móciková H; Hynková L; Šušol O; Kováčová I; Belada D; Hájek R.
Ann Hematol
(Unknown)
Published: 2023
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in c…
Mulas O; Abruzzese E; Luciano L; Iurlo A; Attolico I; Castagnetti F; Galimberti S; Bonifacio M; Annunziata M; Gozzini A; Orlandi EM; Stagno F; Binotto G; Pregno P; Fozza C; Loi M; Trawinska MM; De Gregorio F; Cattaneo D; Albano F; Iezza M; Baratè C; Scaffidi L; Elena C; Giai V; Scalzulli E; Breccia M; La Nasa G; Caocci G.
Ann Hematol
(Unknown)
Published: 2023
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of…
Schrezenmeier H; Kulasekararaj A; Mitchell L; de Latour RP; Devos T; Okamoto S; Wells R; Popoff E; Cheung A; Wang A; Tomazos I; Patel Y; Lee JW.
Ann Hematol
(Unknown)
Published: 2023
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibit…
Koschmieder S; Isfort S; Schulte C; Jacobasch L; Geer T; Reiser M; Koenigsmann M; Heinrich B; Wehmeyer J; von der Heyde E; Tesch H; Gröschl B; Bachhuber P; Großer S; Pahl HL.
Ann Hematol
(Unknown)
Published: 2023
Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in …
Romanová G; Smejkal P; Ovesná P; Drbohlavová E; Dulíček P; Hajšmanová Z; Hluší A; Hrdličková R; Ullrychová J; Vonke I; Blatný J; Čermáková Z; Zápotocká E; Penka M.
Ann Hematol
(Unknown)
Published: 2023
Excellent outcome of stem cell transplantation for sickle cell disease.
Ann Hematol
(Unknown)
Published: 2023
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/r…
Horigome Y; Iino M; Harazaki Y; Kobayashi T; Handa H; Hiramatsu Y; Kuroi T; Tanimoto K; Matsue K; Abe M; Ishida T; Ito S; Iwasaki H; Kuroda J; Shibayama H; Sunami K; Takamatsu H; Tamura H; Hayashi T; Akagi K; Maeda T; Yoshida T; Mori I; Shinozaki T; Iida S.
Ann Hematol
(Unknown)
Published: 2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
Visentini M; Pica A; D'Ippolito G; Sculco E; La Gualana F; Gragnani L; Miglionico M; Mazzaro C; Fiorilli M; Basili S; Martelli M; Di Rocco A; Casato M; Gentile G; Pulsoni A.
Ann Hematol
(Unknown)
Published: 2023